Literature DB >> 28684997

Synthesis of tert-butyl (substituted benzamido)phenylcarbamate derivatives: anti-inflammatory activity and docking studies.

Shankar Bhookya1, Jalapathi Pochampally1, Anil Valeru1, Vianala Sunitha1, Saikrishna Balabadra2, Vijjulatha Manga2, Karunakar Rao Kudle3.   

Abstract

A series of new tert-butyl 2-(substituted benzamido) phenylcarbamate (4a-4j) were synthesized by the condensation of tert-butyl 2-amino phenylcarbamate (3) with various substituted carboxylic acid in the presence of EDCI and HOBt as coupling reagent, obtain in excellent yields. The structures of all newly synthesized compounds were characterized spectroscopically and evaluated for in vivo anti-inflammatory activity compared to the standard drug, indomethacin, by using the carrageenan-induced rat paw edema protocol. Most of the compounds exhibited a promising anti-inflammatory activity within 9 to 12 h, the percentage of inhibition values ranging from 54.239 to 39.021%. The results revealed that the compounds 4i and 4a exhibited better or equivalent anti-inflammatory activity with the percentage of inhibition of 54.239 and 54.130%, respectively, which was comparable to standard drug. In addition to experimental results, in silico docking studies was used as a tool to verify and expand the experimental outcomes.

Entities:  

Keywords:  Amide derivatives; Anti-inflammatory activity; Docking studies; Paw edema

Year:  2017        PMID: 28684997      PMCID: PMC5480262          DOI: 10.1007/s12154-017-0168-x

Source DB:  PubMed          Journal:  J Chem Biol        ISSN: 1864-6158


  25 in total

Review 1.  Heterocyclic compounds as inflammation inhibitors.

Authors:  Sham M Sondhi; Nidhi Singhal; Monika Johar; B S Narayan Reddy; J William Lown
Journal:  Curr Med Chem       Date:  2002-05       Impact factor: 4.530

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Synthesis and biological evaluation of new cyclic amidine analogs of chlorambucil.

Authors:  Anna Bielawska; Krzysztof Bielawski; Anna Muszyńska
Journal:  Farmaco       Date:  2004-02

4.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.

Authors:  R G Kurumbail; A M Stevens; J K Gierse; J J McDonald; R A Stegeman; J Y Pak; D Gildehaus; J M Miyashiro; T D Penning; K Seibert; P C Isakson; W C Stallings
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

Review 5.  Cyclooxygenase inhibitors--current status and future prospects.

Authors:  G Dannhardt; W Kiefer
Journal:  Eur J Med Chem       Date:  2001-02       Impact factor: 6.514

Review 6.  Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.

Authors:  Francis K L Chan
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-10

7.  Synthesis of amidine and amide derivatives and their evaluation for anti-inflammatory and analgesic activities.

Authors:  Sham M Sondhi; Jaiveer Singh; Ashok Kumar; Hyder Jamal; P P Gupta
Journal:  Eur J Med Chem       Date:  2008-07-04       Impact factor: 6.514

8.  Amidinobenzisothiazole derivatives with antidegenerative activity on cartilage.

Authors:  Annamaria Panico; Paola Vicini; Matteo Incerti; Venera Cardile; Barbara Gentile; Giuseppe Ronsisvalle
Journal:  Farmaco       Date:  2002-08

9.  Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.

Authors:  C C Chan; S Boyce; C Brideau; A W Ford-Hutchinson; R Gordon; D Guay; R G Hill; C S Li; J Mancini; M Penneton
Journal:  J Pharmacol Exp Ther       Date:  1995-09       Impact factor: 4.030

10.  Anti-inflammatory screening and molecular modeling of some novel coumarin derivatives.

Authors:  Radwan El-Haggar; Reem I Al-Wabli
Journal:  Molecules       Date:  2015-03-26       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.